Brief: Alkem Labs Says US FDA Conducts Unannounced Inspection At Alkem CRO Facility
08/05/2026 15:07
May 8 (Reuters) - Alkem Laboratories Ltd ALKE.NS: ALKEM LABS - US FDA CONDUCTS UNANNOUNCED INSPECTION AT ALKEM CRO FACILITY ON 08 MAY 2026 ALKEM LABS - AT END OF INSPECTION, NO FORM 483 WAS ISSUED Source text: ID:nBSEFVjNs Further company coverage: ALKE.NS ((reuters.briefs@thomsonreuters.com;))
Recent news on Alkem Laboratories
See all newsBrief: Alkem Labs Approved Initiation Of Forensic Audit In Connection With Recent Incident Involving Alleged Misappropriation Of Funds By A Former Employee
Brief: Alkem Labs Launches Neuceno (Cenobamate) For Treatment Of Partial-Onset Seizures In Adult Patients
Brief: Alkem Labs Launches Renocia Exo, Ginsenoside Exosome-Based Hair Growth Serum
Brief: Alkem Labs Board Approves Investment Of Up To 750 Million Rupees For New Block At Baddi Manufacturing Facility
Brief: Alkem Laboratories Q1 Consol Revenue From Operations 37.4 Billion Rupees